Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
PRVA
PRVA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PRVA News
BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares
5d ago
NASDAQ.COM
BlackBarn Capital Increases Warby Parker Stake to 3 Million Shares
5d ago
Fool
EHR-Enabled Colorectal Cancer Screening Achieves Significant Impact
Mar 03 2026
Newsfilter
Privia Health Reports Strong Q4 2025 Earnings and Growth Outlook
Feb 26 2026
seekingalpha
Privia Health (PRVA) Q4 2025 Earnings Transcript
Feb 26 2026
NASDAQ.COM
Privia Health Reports Q4 Earnings Beat Expectations
Feb 26 2026
seekingalpha
BMO Capital Begins Coverage of Privia Health Group with Outperform Rating and Sets Price Target at $30
Nov 13 2025
Benzinga
Evercore ISI Group Reaffirms Outperform Rating for Privia Health Group, Increases Price Target to $30
Nov 07 2025
Benzinga
Privia Health: Overview of Q3 Earnings
Nov 06 2025
Yahoo Finance
Barclays Keeps Equal-Weight Rating on Privia Health Group (PRVA)
Oct 10 2025
NASDAQ.COM
Privia Health Scheduled to Announce Q3 2025 Results on Thursday, November 6
Oct 07 2025
Newsfilter
Projected Target Price for FYC Analyst: $104
Oct 02 2025
NASDAQ.COM
Privia Health Purchases Evolent's ACO Division to Enhance Value-Based Care
Sep 24 2025
Benzinga
Evolent Announces Strategic Divestiture of its Value-Based Primary Care Business, Evolent Care Partners
Sep 23 2025
PRnewswire
Midday Stock Highlights: Petco Health, Celsius, Affirm, Caterpillar, and Others Making Significant Moves
Aug 29 2025
CNBC
JMP Securities Keeps Market Outperform Rating for Privia Health Group, Increases Price Target to $30
Aug 29 2025
Benzinga
Show More News
